S&P 500   3,325.54 (+0.11%)
DOW   29,160.09 (-0.09%)
QQQ   224.59 (+0.32%)
AAPL   319.23 (+0.48%)
FB   219.76 (-0.70%)
MSFT   166.72 (+0.62%)
GOOGL   1,484.69 (+0.04%)
AMZN   1,884.58 (-0.15%)
CGC   24.56 (+1.82%)
NVDA   252.86 (+1.12%)
BABA   219.13 (-1.46%)
MU   59.20 (+0.05%)
GE   11.77 (+3.52%)
TSLA   572.20 (+0.46%)
AMD   51.71 (+0.54%)
ACB   2.07 (+1.47%)
F   9.14 (-0.22%)
NFLX   349.60 (+7.24%)
PRI   125.55 (-0.87%)
BAC   34.12 (-0.70%)
DIS   142.20 (-1.26%)
GILD   63.94 (+0.80%)
S&P 500   3,325.54 (+0.11%)
DOW   29,160.09 (-0.09%)
QQQ   224.59 (+0.32%)
AAPL   319.23 (+0.48%)
FB   219.76 (-0.70%)
MSFT   166.72 (+0.62%)
GOOGL   1,484.69 (+0.04%)
AMZN   1,884.58 (-0.15%)
CGC   24.56 (+1.82%)
NVDA   252.86 (+1.12%)
BABA   219.13 (-1.46%)
MU   59.20 (+0.05%)
GE   11.77 (+3.52%)
TSLA   572.20 (+0.46%)
AMD   51.71 (+0.54%)
ACB   2.07 (+1.47%)
F   9.14 (-0.22%)
NFLX   349.60 (+7.24%)
PRI   125.55 (-0.87%)
BAC   34.12 (-0.70%)
DIS   142.20 (-1.26%)
GILD   63.94 (+0.80%)
S&P 500   3,325.54 (+0.11%)
DOW   29,160.09 (-0.09%)
QQQ   224.59 (+0.32%)
AAPL   319.23 (+0.48%)
FB   219.76 (-0.70%)
MSFT   166.72 (+0.62%)
GOOGL   1,484.69 (+0.04%)
AMZN   1,884.58 (-0.15%)
CGC   24.56 (+1.82%)
NVDA   252.86 (+1.12%)
BABA   219.13 (-1.46%)
MU   59.20 (+0.05%)
GE   11.77 (+3.52%)
TSLA   572.20 (+0.46%)
AMD   51.71 (+0.54%)
ACB   2.07 (+1.47%)
F   9.14 (-0.22%)
NFLX   349.60 (+7.24%)
PRI   125.55 (-0.87%)
BAC   34.12 (-0.70%)
DIS   142.20 (-1.26%)
GILD   63.94 (+0.80%)
S&P 500   3,325.54 (+0.11%)
DOW   29,160.09 (-0.09%)
QQQ   224.59 (+0.32%)
AAPL   319.23 (+0.48%)
FB   219.76 (-0.70%)
MSFT   166.72 (+0.62%)
GOOGL   1,484.69 (+0.04%)
AMZN   1,884.58 (-0.15%)
CGC   24.56 (+1.82%)
NVDA   252.86 (+1.12%)
BABA   219.13 (-1.46%)
MU   59.20 (+0.05%)
GE   11.77 (+3.52%)
TSLA   572.20 (+0.46%)
AMD   51.71 (+0.54%)
ACB   2.07 (+1.47%)
F   9.14 (-0.22%)
NFLX   349.60 (+7.24%)
PRI   125.55 (-0.87%)
BAC   34.12 (-0.70%)
DIS   142.20 (-1.26%)
GILD   63.94 (+0.80%)
Log in

Agios Pharmaceuticals News Headlines (NASDAQ:AGIO)

$53.25
-0.56 (-1.04 %)
(As of 01/23/2020 04:00 PM ET)
Today's Range
$53.06
Now: $53.25
$54.17
50-Day Range
$39.99
MA: $47.78
$53.81
52-Week Range
$28.36
Now: $53.25
$68.94
Volume571,226 shs
Average Volume879,524 shs
Market Capitalization$3.14 billion
P/E RatioN/A
Dividend YieldN/A
Beta2.35

Headlines

Agios Pharmaceuticals (NASDAQ AGIO) News Headlines

Source:
DateHeadline
Oppenheimer Comments on Agios Pharmaceuticals Incs FY2024 Earnings (NASDAQ:AGIO)Oppenheimer Comments on Agios Pharmaceuticals Inc's FY2024 Earnings (NASDAQ:AGIO)
www.americanbankingnews.com - January 23 at 9:58 AM
$31.10 Million in Sales Expected for Agios Pharmaceuticals Inc (NASDAQ:AGIO) This Quarter$31.10 Million in Sales Expected for Agios Pharmaceuticals Inc (NASDAQ:AGIO) This Quarter
www.americanbankingnews.com - January 23 at 4:46 AM
Agios Pharmaceuticals (NASDAQ:AGIO) Receives Hold Rating from OppenheimerAgios Pharmaceuticals (NASDAQ:AGIO) Receives Hold Rating from Oppenheimer
www.americanbankingnews.com - January 22 at 7:09 AM
Zacks: Analysts Expect Agios Pharmaceuticals Inc (NASDAQ:AGIO) to Post -$1.81 Earnings Per ShareZacks: Analysts Expect Agios Pharmaceuticals Inc (NASDAQ:AGIO) to Post -$1.81 Earnings Per Share
www.americanbankingnews.com - January 21 at 9:17 AM
Analysts: 3 Healthcare Stocks That Could Gain 35% — Or MoreAnalysts: 3 Healthcare Stocks That Could Gain 35% — Or More
finance.yahoo.com - January 17 at 10:49 PM
3 Top Healthcare Stocks That Could Gain 35% — Or More3 Top Healthcare Stocks That Could Gain 35% — Or More
finance.yahoo.com - January 17 at 12:48 PM
Agios Pharmaceuticals (AGIO) Presents At 38th Annual J.P. Morgan Healthcare Conference - SlideshowAgios Pharmaceuticals (AGIO) Presents At 38th Annual J.P. Morgan Healthcare Conference - Slideshow
seekingalpha.com - January 14 at 4:42 PM
Agios Pharmaceuticals (NASDAQ:AGIO) Stock Rating Reaffirmed by CowenAgios Pharmaceuticals (NASDAQ:AGIO) Stock Rating Reaffirmed by Cowen
www.americanbankingnews.com - January 14 at 11:51 AM
Traders Buy High Volume of Agios Pharmaceuticals Put Options (NASDAQ:AGIO)Traders Buy High Volume of Agios Pharmaceuticals Put Options (NASDAQ:AGIO)
www.americanbankingnews.com - January 14 at 7:48 AM
Aptevo Therapeutics Apvo436 Selected For Inclusion In The Leukemia & Lymphoma Societys Groundbreaking Beat Aml(R) Master Clinical TrialAptevo Therapeutics' Apvo436 Selected For Inclusion In The Leukemia & Lymphoma Society's Groundbreaking Beat Aml(R) Master Clinical Trial
www.marketwatch.com - January 13 at 4:20 PM
Agios: A Targeted Pharmaceutical Stairway To ValueAgios: A Targeted Pharmaceutical Stairway To Value
seekingalpha.com - January 13 at 4:20 PM
BRIEF-Agios Announces “Agios 2025” Strategic Vision And Highlights 2020 MilestonesBRIEF-Agios Announces “Agios 2025” Strategic Vision And Highlights 2020 Milestones
www.msn.com - January 12 at 9:06 PM
Agios sees Tibsovo sales as high as $115M this yearAgios sees Tibsovo sales as high as $115M this year
seekingalpha.com - January 12 at 9:06 PM
Agios Pharmaceuticals Inc (NASDAQ:AGIO) Given Average Recommendation of "Buy" by AnalystsAgios Pharmaceuticals Inc (NASDAQ:AGIO) Given Average Recommendation of "Buy" by Analysts
www.americanbankingnews.com - January 10 at 12:02 PM
Foghorn® Therapeutics Appoints Scott Biller, Ph.D., to Board of DirectorsFoghorn® Therapeutics Appoints Scott Biller, Ph.D., to Board of Directors
www.marketwatch.com - January 9 at 3:21 PM
What Makes Agios Pharmaceuticals (AGIO) a New Buy StockWhat Makes Agios Pharmaceuticals (AGIO) a New Buy Stock
finance.yahoo.com - January 7 at 5:31 PM
Agios Pharmaceuticals Inc (NASDAQ:AGIO) Insider Carman Alenson Sells 2,950 SharesAgios Pharmaceuticals Inc (NASDAQ:AGIO) Insider Carman Alenson Sells 2,950 Shares
www.americanbankingnews.com - December 31 at 5:13 PM
-$1.81 Earnings Per Share Expected for Agios Pharmaceuticals Inc (NASDAQ:AGIO) This Quarter-$1.81 Earnings Per Share Expected for Agios Pharmaceuticals Inc (NASDAQ:AGIO) This Quarter
www.americanbankingnews.com - December 29 at 10:22 AM
Agios to Present at the 38th Annual J.P. Morgan Healthcare Conference on Monday, January 13, 2020Agios to Present at the 38th Annual J.P. Morgan Healthcare Conference on Monday, January 13, 2020
finance.yahoo.com - December 23 at 9:08 AM
Agios Tibsovo Wins FDAs Breakthrough Therapy Tag for MDSAgios' Tibsovo Wins FDA's Breakthrough Therapy Tag for MDS
finance.yahoo.com - December 17 at 2:30 PM
Agios Climbs as Cancer Drug Gets FDA BoostAgios Climbs as Cancer Drug Gets FDA Boost
www.barrons.com - December 17 at 9:30 AM
Agios Pharmas Tibsovo nabs accelerated review in U.S. for type of MDSAgios Pharma's Tibsovo nabs accelerated review in U.S. for type of MDS
seekingalpha.com - December 16 at 5:48 PM
Agios Receives FDA Breakthrough Therapy Designation for TIBSOVO® (ivosidenib) for the Treatment of Adult Patients with Relapsed or Refractory Myelodysplastic Syndrome with an IDH1 MutationAgios Receives FDA Breakthrough Therapy Designation for TIBSOVO® (ivosidenib) for the Treatment of Adult Patients with Relapsed or Refractory Myelodysplastic Syndrome with an IDH1 Mutation
finance.yahoo.com - December 16 at 5:48 PM
These Hedge Funds Cashed Out Of Agios Pharmaceuticals Inc (AGIO) Too EarlyThese Hedge Funds Cashed Out Of Agios Pharmaceuticals Inc (AGIO) Too Early
finance.yahoo.com - December 13 at 12:45 PM
Edited Transcript of AGIO earnings conference call or presentation 14-Feb-18 1:00pm GMTEdited Transcript of AGIO earnings conference call or presentation 14-Feb-18 1:00pm GMT
finance.yahoo.com - December 13 at 7:45 AM
Agios Pharmaceuticals (AGIO) Presents At 2019 ASH Annual Meeting - SlideshowAgios Pharmaceuticals (AGIO) Presents At 2019 ASH Annual Meeting - Slideshow
seekingalpha.com - December 11 at 12:32 PM
BRIEF-Agios Presents Updated Data For Mitapivat From Extension Phase Of Drive PK Study In Patients With Pyruvate Kinase DeficiencyBRIEF-Agios Presents Updated Data For Mitapivat From Extension Phase Of Drive PK Study In Patients With Pyruvate Kinase Deficiency
www.msn.com - December 9 at 10:30 PM
Agios up 13% premarket positive Tibsovo dataAgios up 13% premarket positive Tibsovo data
seekingalpha.com - December 9 at 12:29 PM
BRIEF-Agios Pharmaceuticals Establishes Proof-Of-Concept For Mitapivat In Non-Transfusion-Dependent Thalassemia Based On Preliminary Phase 2 ResultsBRIEF-Agios Pharmaceuticals Establishes Proof-Of-Concept For Mitapivat In Non-Transfusion-Dependent Thalassemia Based On Preliminary Phase 2 Results
www.msn.com - December 8 at 7:17 PM
Agios Establishes Proof-of-Concept for Mitapivat in Non-transfusion-dependent Thalassemia Based on Preliminary Phase 2 ResultsAgios Establishes Proof-of-Concept for Mitapivat in Non-transfusion-dependent Thalassemia Based on Preliminary Phase 2 Results
finance.yahoo.com - December 8 at 2:16 PM
Agios Appoints Bruce Car, Ph.D., as Chief Scientific OfficerAgios Appoints Bruce Car, Ph.D., as Chief Scientific Officer
finance.yahoo.com - December 2 at 9:51 AM
Agios Pharmaceuticals Raised $294 Million to Fight Cancer and Rare Genetic Diseases: What It Means for InvestorsAgios Pharmaceuticals Raised $294 Million to Fight Cancer and Rare Genetic Diseases: What It Means for Investors
www.fool.com - November 27 at 2:06 PM
Agios Appoints Jonathan Biller as Chief Legal OfficerAgios Appoints Jonathan Biller as Chief Legal Officer
finance.yahoo.com - November 25 at 8:48 AM
Agios Pharma +5.8% amid new vorasidenib progressAgios Pharma +5.8% amid new vorasidenib progress
seekingalpha.com - November 23 at 12:05 AM
Agios Presents New Pharmacodynamic and Response Data from Both Cohorts of the Perioperative Study of Vorasidenib and TIBSOVO® (ivosidenib) in Patients with IDH1 Mutant Positive Low-Grade GliomaAgios Presents New Pharmacodynamic and Response Data from Both Cohorts of the Perioperative Study of Vorasidenib and TIBSOVO® (ivosidenib) in Patients with IDH1 Mutant Positive Low-Grade Glioma
finance.yahoo.com - November 22 at 7:04 PM
First Week of January 2020 Options Trading For Agios Pharmaceuticals (AGIO)First Week of January 2020 Options Trading For Agios Pharmaceuticals (AGIO)
www.nasdaq.com - November 21 at 9:29 AM
AGIO Agios Pharmaceuticals, Inc. Common StockAGIO Agios Pharmaceuticals, Inc. Common Stock
www.nasdaq.com - November 8 at 4:23 PM
Agios Announces Pricing of $256 Million Public Offering of Common StockAgios Announces Pricing of $256 Million Public Offering of Common Stock
finance.yahoo.com - November 8 at 12:21 AM
Agios down 4% premarket on equity offeringAgios down 4% premarket on equity offering
seekingalpha.com - November 6 at 6:02 PM
BRIEF-Agios Pharma Says Will Not File SNDA For TibsovoBRIEF-Agios Pharma Says Will Not File SNDA For Tibsovo
www.msn.com - November 6 at 12:05 AM
Edited Transcript of AGIO earnings conference call or presentation 31-Oct-19 12:00pm GMTEdited Transcript of AGIO earnings conference call or presentation 31-Oct-19 12:00pm GMT
finance.yahoo.com - November 4 at 5:55 PM
Agios Pharmaceuticals, Inc. 2019 Q3 - Results - Earnings Call PresentationAgios Pharmaceuticals, Inc. 2019 Q3 - Results - Earnings Call Presentation
seekingalpha.com - November 4 at 7:54 AM
Relative Strength Alert For Agios PharmaceuticalsRelative Strength Alert For Agios Pharmaceuticals
www.nasdaq.com - November 1 at 7:07 PM
Agios (AGIO) Q3 Loss Narrower Than Expected, Revenues MissAgios' (AGIO) Q3 Loss Narrower Than Expected, Revenues Miss
www.nasdaq.com - November 1 at 7:07 PM
BRIEF-Agios Reports Business Highlights And Third Quarter 2019 Financial ResultsBRIEF-Agios Reports Business Highlights And Third Quarter 2019 Financial Results
www.msn.com - October 31 at 11:10 PM
The Daily Biotech Pulse: Agile Receives Favorable Adcom Verdict, Merit Medical Tumbles On Earnings, 2 Biotechs To DebutThe Daily Biotech Pulse: Agile Receives Favorable Adcom Verdict, Merit Medical Tumbles On Earnings, 2 Biotechs To Debut
finance.yahoo.com - October 31 at 1:09 PM
Agios Pharmaceuticals (AGIO) Reports Q3 Loss, Misses Revenue EstimatesAgios Pharmaceuticals (AGIO) Reports Q3 Loss, Misses Revenue Estimates
finance.yahoo.com - October 31 at 1:09 PM
Agios Pharmaceuticals EPS misses by $0.02, misses on revenueAgios Pharmaceuticals EPS misses by $0.02, misses on revenue
seekingalpha.com - October 31 at 7:51 AM
Agios Reports Business Highlights and Third Quarter 2019 Financial ResultsAgios Reports Business Highlights and Third Quarter 2019 Financial Results
finance.yahoo.com - October 31 at 7:51 AM
Agios Pharmaceuticals Inc (AGIO) Is Burning These Hedge FundsAgios Pharmaceuticals Inc (AGIO) Is Burning These Hedge Funds
finance.yahoo.com - October 31 at 12:12 AM
This page was last updated on 1/23/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel